- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Risk factors determine need for CTA for PE
Risk factor assessments can rule out the need for CT angiography for pulmonary embolism, according to a new study published in Radiology.
Risk factor assessments can rule out the need for CT angiography for pulmonary embolism, according to a new study published in Radiology.
CT angiograms were negative for pulmonary embolism (PE) in 90.2% of 2003 patients, according to researchers at the University of California, Irvine. Among the 197 patients positive for PE, 97.5% had one or more risk factors. The risk factors were age, gender, cancer, history of immbolization, excess estrogen rate, a history of venous thromboembolism, and disorders that cause blood to clot easily.
All risk factors except gender were considered statistically significant. Age of 65 years or older and immobilization were the most common risk factors in positive PE patients. Risk factor assessment had a sensitivity of 97.5% and a negative predictive value of 99% in all patients.
Of the patients negative for PE, 28.8% had no risk factors. Excluding age and gender brought that figure to 62%.
Results were published online June 15 (Epub ahead of print).
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Researchers Show Higher Breast Cancer Upstaging Rate with 18F-FAPI PET/CT
September 9th 2024The imaging agent 18F-FAPI PET/CT demonstrated greater than a 45 percent higher sensitivity rate in comparison to 18F-FDG PET/CT for the detection of axillary and extraaxillary regional lymph node metastases, according to a lesion-based analysis from a recent study.
